We found that similar to cisplatin, methotrexate, an anti-folate antimetabolite chemotherapy commonly used for acute lymphocytic leukemia and breast cancer, also significantly increases the expression levels of COX-2 in vivo and in vitro (Supplementary Figure 1). Here, PTGS2 is linked to breast cancer.